A detailed history of Cap Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cap Partners, LLC holds 3,616 shares of BMY stock, worth $205,569. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,616
Holding current value
$205,569
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$51.92 - $59.94 $187,742 - $216,743
3,616 New
3,616 $205 Million
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $335 - $380
-7 Reduced 0.16%
4,290 $233 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $208,318 - $248,581
4,297 New
4,297 $220 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cap Partners, LLC Portfolio

Follow Cap Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cap Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cap Partners, LLC with notifications on news.